Syndax Pharma Prices Public Offering Of About 6.82 Mln Shares At $22.00/shr

Syndax Pharmaceuticals Inc. (SNDX) said that it has priced an underwritten public offering of about 6.82 million shares of its common stock at $22.00 per share.

The aggregate gross proceeds from the offering are expected to be approximately $150.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by Syndax.

In addition, Syndax granted the underwriters a 30-day option to purchase up to an additional 1.02 million shares of common stock. The offering is expected to close on December 9, 2022, subject to customary closing conditions.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ride-hailing and delivery platform Uber Technologies, Inc. reported Wednesday weak profit in its fourth quarter, while adjusted EBITDA surged from last year with strong revenue growth above market view. Gross bookings increased and the company projects higher gross bookings in the first quarter. Nelson Chai, CFO, said the company significantly exceeded profitability outlook in 2022, ... Societe Generale Group reported Wednesday a weak profit in its fourth quarter, despite higher net banking income. Further, the French Financial services major proposed a dividend and around 440 million euros share buyback program. The company also confirmed fiscal 2025 financial targets. City of Industry, California-based Titans Global Inc. is recalling certain JSJ branded cakes citing potential to contain undeclared eggs, a known allergen, the U.S. Food and Drug Administration said. The recall involves its 95g packages of JSJ Chocolate Cake, JSJ ZSR Cake, and JSJ DMC Leaf Cake food treats.
Follow RTT